Day: May 27, 2022

Correction: Resolutions of Snaige AB the General Meeting of Shareholders

Correction: Resolutions of Snaige AB the General Meeting of Shareholders

Correction: the table of the distribution of profit (loss) on resolution No. 4 has been corrected due to a misprint. The General Meeting of Shareholders of Snaige AB was held on 29 April 2022. The following resolutions were made at the meeting: 1. Consolidated annual report of “Snaigė” AB on the company’s activity for 2021;Taken for information the consolidated annual report of “Snaigė”, shareholders approved remuneration report;2. Auditor’s conclusion on the company’s financial statements for 2021;Taken for information the auditor’s conclusion on the company’s financial statements for 2021 year;3. Approval of the set of financial statements of the company for 2021;Approved the set of consolidated and the company’s financial statements for 2021 year;4. Approval of distribution of profit (loss) of  “Snaigė” AB for 2021;Approved the distribution...

Continue reading

Foresight Enterprise VCT plc - Dividend Declaration

Foresight Enterprise VCT plc – Dividend Declaration

FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 DIVIDEND DECLARATION The Board of Foresight Enterprise VCT plc is pleased to declare an interim dividend relating to the year ended 31 December 2021 of 3.5p per share, which will be paid on 30 June 2022. The shares will be quoted ex-dividend on 16 June 2022 and the record date for payment will be 17 June 2022. For further information, please contact: Company SecretaryForesight Group LLPContact: Gary Fraser Tel: 0203 667 8100 Investor RelationsForesight Group LLPContact: Ellie Kakoulli Tel: 0203 667 8181

Continue reading

EnWave Reports 2022 Second Quarter Consolidated Interim Financial Results

EnWave Reports 2022 Second Quarter Consolidated Interim Financial Results

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V: ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2022. Q2 YTD royalties grew to $750K representing 55% growth in our high-margin royalty base year-over-year. NutraDried’s Q2 revenue grew by 142% relative to Q1 with material new Moon Cheese® distribution into Kroger and a Costco Canada program. NutraDried launched Moon Cheese® Crunchy Sticks with Whole Foods Market and confirmed its second major distribution commitment from Walmart in 400 U.S. stores. REVworx™ facility is operational and progress is underway to obtain food safety certifications. EnWave’s potential new royalty partner pipeline is robust with six active technology...

Continue reading

Discovery Reports Q1 2022 Financial Results and Update

Discovery Reports Q1 2022 Financial Results and Update

TORONTO, May 27, 2022 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce its financial results for the three months ended March 31, 2022 (“Q1 2022”), and provide a summary of key events for the quarter, and subsequent to quarter-end. All amounts are presented in Canadian dollars (“C$”) unless otherwise stated. Discovery’s flagship project is our 100%-owned Cordero silver project (“Cordero” or the “Project”) located in Chihuahua State, Mexico. Following the completion of a Preliminary Economic Assessment (“PEA”) in 2021 that demonstrated Cordero is a large-scale, high-margin asset with a long mine life, our focus now is the delivery of a Pre-Feasibility Study (“PFS”) on the Project in the fourth quarter of this year. HIGHLIGHTS FROM Q1 2022 & SUBSEQUENT...

Continue reading

CYIOS CORP WHOLLY OWNED SUBSIDIARY IMMORTALS GROUP IN COLLABORATION WITH SLH, LTD ANNOUNCE LOST SPIDER-MAN PARODY - ‘SLAM-GIRL’ TO PREVIEW AT METACON DUBAI POWERED BY GALA GAMES

CYIOS CORP WHOLLY OWNED SUBSIDIARY IMMORTALS GROUP IN COLLABORATION WITH SLH, LTD ANNOUNCE LOST SPIDER-MAN PARODY – ‘SLAM-GIRL’ TO PREVIEW AT METACON DUBAI POWERED BY GALA GAMES

Never-Before-Released Slam-Girl Superhero created in 2000 by Stan Lee and Marvel Animator Will Meugniot Uncovered by Former Marvel Comics Publisher Shirrel Rhoades will be showcased at MetaCon DUBAI, UAE, May 27, 2022 (GLOBE NEWSWIRE) — CYIOS Corp (OTC PINK: CYIO) – Dubai’s version of Comic-Con for the Metaverse, “MetaCon- Into the Metaverse” powered by GALA is being held this weekend at The Arena, Dubai World Trade Center. CYIOS Corp’s wholly owned subsidiary Immortals Group PTY (AU), in collaboration with SLH, LTD is pleased to announce the Slam-Girl CYBERspace NFT Collection will be previewed at Metacon along with the long-lost introductory webisode of Stan Lee’s Slam-Girl, the first super hero created to live in the Metaverse in a place called Stanleyville. Former Marvel Comics Publisher Shirrel Rhoades, who recently...

Continue reading

CORRECTING and REPLACING - Hepion Pharmaceuticals, Inc.

CORRECTING and REPLACING – Hepion Pharmaceuticals, Inc.

EDISON, N.J., May 27, 2022 (GLOBE NEWSWIRE) — In the press release issued earlier today by Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), we’ve been informed by the company that in both the headline and first paragraph the name ‘Recofilstat’ should be ‘Rencofilstat’. Completed corrected text follows.  Hepion Pharmaceuticals Highlights Upcoming Phase 2 Clinical Trials of Rencofilstat at 5th Global NASH Congress Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and hepatocellular carcinoma (“HCC”), announces that its Chief Medical Officer, Todd Hobbs, MD, gave a clinical presentation entitled “Rencofilstat (CRV431): A liver-targeting...

Continue reading

Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World Conference

Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World Conference

New York, NY, and Tel Aviv, ISRAEL, May 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that majority-owned subsidiary 3CL Pharma will present final data from the phase 2 clinical trial of Tollovir™ in the treatment of hospitalized (severe and critical) COVID-19 patients at the Personalized Medicine World Conference (PMWC) on June 30th, 2022 at 1:30pm Pacific Time.    “While the Company announced positive topline clinical results from this trial in late January earlier this year, it became clear that the final dataset with the biomarker data and other key clinical data results were going to be critical to allow the market to understand the full impact that Tollovir™ could have on the standard care in treatment...

Continue reading

Unaudited financial results of Nordic Fibreboard AS for the first quarter of 2022

Unaudited financial results of Nordic Fibreboard AS for the first quarter of 2022

MANAGEMENT REPORT Nordic Fibreboard AS unaudited results for first quarter of 2022 Consolidated net sales for Q1 2022 were € 2.60 million (down 8% compared to Q1 2021). The main business area is the production and wholesale of fibreboard, which recorded sales in Q1 2022 of € 2.59 million (down 6% compared to Q1 2021). The remaining business area is real estate management of the property owned in Suur-Jõe street in Pärnu, who recorded sales of € 0.01 million in Q1 2022 (down from sales of € 0.08 million in Q1 2021). Sales from production of fibreboards in Q1 2022 experienced a decline from Q1 2021 due to less volume sold as a consequence of more stoppages on the production line. Demand for our fibreboards during Q1 2022 was very strong, and production was running at full capacity. Delivery times to our key customers was on average 3 months,...

Continue reading

Ackroo Releases Q1 2022 Financial Results

Ackroo Releases Q1 2022 Financial Results

Ackroo delivers 21% YoY revenue and 13% YoY EBITDA as a percentage of revenue growth HAMILTON, Ontario, May 27, 2022 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a loyalty marketing, payments and point-of-sale technology and services provider, has filed its financial results for the period ended March 31, 2022. The results for the period ended March 31st, 2022 reflect 21% year over year revenue growth, and a 28% increase in subscription revenue over the same period in 2021. The Company also achieved $224,965 of positive adjusted EBITDA during the quarter representing a year over year increase of 2,674% and equates to 14% of total revenues. The Company expects these positive trends to continue as they execute on their renewed plans to consolidate, simplify and improve the merchant marketing, payments...

Continue reading

Selection of candidates for members of the Supervisory Council of AB Klaipėdos nafta is announced

Selection of candidates for members of the Supervisory Council of AB Klaipėdos nafta is announced

On 27 May, 2022 Ministry of Energy of the Republic of Lithuania, announced a selection of candidates for members of the Supervisory Council of AB Klaipėdos nafta (hereinafter – the Company). The selection is announced for three members of the Supervisory Council of the Company: one for an independent member of the Supervisory Council in the field of finance management and audit, one for an independent member of the Supervisory Council in the field of strategic planning and management and one civil servant member of the Supervisory Council. The selection shall be performed according to the Description of Selection of Candidates for the Board of State or Municipal Enterprise and Candidates for Collegial Supervisory or Management Body Elected by the General Meeting of Shareholders of State or Municipal-Owned Company, approved by the Resolution...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.